Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

National Healthcare Properties (HLTC) Net Income towards Common Stockholders (2016 - 2025)

National Healthcare Properties (HLTC) has 13 years of Net Income towards Common Stockholders data on record, last reported at -$26.0 million in Q4 2025.

  • For Q4 2025, Net Income towards Common Stockholders fell 27.12% year-over-year to -$26.0 million; the TTM value through Dec 2025 reached -$71.1 million, up 65.08%, while the annual FY2025 figure was -$71.1 million, 65.08% up from the prior year.
  • Net Income towards Common Stockholders reached -$26.0 million in Q4 2025 per HLTC's latest filing, down from -$15.9 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at -$5.0 million in Q1 2025 and bottomed at -$119.9 million in Q2 2024.
  • Average Net Income towards Common Stockholders over 5 years is -$27.3 million, with a median of -$21.6 million recorded in 2022.
  • Peak YoY movement for Net Income towards Common Stockholders: crashed 477.66% in 2024, then soared 79.83% in 2025.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at -$22.8 million in 2021, then rose by 2.78% to -$22.1 million in 2022, then fell by 27.76% to -$28.3 million in 2023, then grew by 27.7% to -$20.4 million in 2024, then fell by 27.12% to -$26.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Net Income towards Common Stockholders were -$26.0 million in Q4 2025, -$15.9 million in Q3 2025, and -$24.2 million in Q2 2025.